IQVIA Digital Site Suite
-
Global Pharma Company Dramatically Improves Collaboration, Communication, And Compliance In Trials
10/9/2020
A Top 5 global pharmaceutical company wanted to help sites do everyday tasks more efficiently, making it easier for site staff to adhere to the protocol and deliver high-quality data. After evaluations and pilots, the company deployed an Investigator Site Portal in a 4-phase approach that delivered benefits each step of the way.
-
How Technology And Relationships Can Improve Feasibility
8/31/2020
Conducting feasibility is an essential and necessary step to starting up a clinical trial. The good news is that the whole approach has the ability to change for the better by initiating and adopting some enhancements.
-
Best Practices For Site Communications During COVID-19
6/8/2020
With so much new and updated information being shared on nearly a daily basis, it’s important to consider the most effective methods of organization and distribution. Here are some best practices we’ve compiled from working with sponsors and sites of all sizes and specialties during the COVID-19 pandemic.
-
IQVIA Learning Management System
5/20/2020
IQVIA’s Learning Management System (LMS) provides sites and study teams with a single, efficient source for education and learning, knowledge assessments, reporting and more.
-
IQVIA Safety Notifications
5/20/2020
Now featuring cross-trial functionality, IQVIA Safety Notifications gives sponsors and contract research organizations (CROs) a centralized, simple solution for disseminating, managing, and tracking SUSARs and other safety notifications.
-
IQVIA Investigator Site Portal
5/20/2020
IQVIA Technologies’ Investigator Site Portal (formerly DrugDev) offers sponsors, CROs, and sites the ability to manage trials easily and efficiently, from beginning to end, by enabling users to communicate effortlessly with sites, design and execute goals, and provide reporting, trial metrics, and much more.
-
How To Boost Support To Sites With Digital Clinical Technologies During The COVID-19 Crisis And Beyond
5/9/2020
Digital solutions previously viewed as “nice to have” for clinical trial optimization are now proving to be vital to support sites. Here are five areas where we have seen sponsors take advantage of digital clinical technologies to boost support to sites and enable innovative drug development to continue - not only during the COVID-19 crisis but well into the future.
-
Staying Connected In Crisis: Strong Site Communication Channels Stand Up To Pressure
4/14/2020
The COVID-19 pandemic is presenting unprecedented challenges to the clinical trial industry. Sites are in an unprecedented state of flux, and the pressure to understand the situation, protect patients and providers, and determine how to ensure continuity is on. Now more than ever, strong communication channels between sponsors and sites are critical.
-
Considerations When Implementing New Technology At Clinical Trial Sites
3/3/2020
More than 10 years ago, the digital revolution came to the clinical trials industry, ushering in a host of new technologies for sites worldwide. While a few technologies were lauded, many sites found themselves overwhelmed by the sheer number of new offerings and frustrated by the numerous solutions proposed by sponsors that ultimately made trials more difficult. There are many steps that organizations can take to implement a site-first approach to ensure their tools aren’t missing the mark.
-
Preventing Information Overload - Using Study Portals To Engage Site Staff
3/2/2020
For many sites, the overabundance of communications through email, system notifications, or other means isn’t just common, it’s standard. To combat this, sponsors have been using study portals to employ a traditional mix of best practices and tailored communication styles. This approach works because it covers the core needs of all clinical trial sites while also addressing the two different types of site users.